Table 2.
Base case results for lifestyle interventions compared to no prevention.
| Outcomes | No prevention | Lifestyle interventions | Difference∗ |
|---|---|---|---|
| Cumulative probabilities of diabetes | 93.57% | 84.04% | -9.53% |
| Cumulative probabilities of complications | |||
| MI | 10.56% | 9.93% | -0.63% |
| Stroke | 24.17% | 22.62% | -1.55% |
| CHF | 14.89% | 13.71% | -1.18% |
| ESRD | 4.61% | 4.22% | -0.39% |
| Blindness | 5.79% | 5.66% | -0.13% |
| Clinical neuropathy | 21.28% | 20.25% | -1.03% |
| Minor amputation | 12.21% | 10.55% | -1.66% |
| Major amputation | 9.22% | 7.94% | -1.28% |
| Total QALY | 13.03 | 13.55 | 0.52 |
| Total LY | 27.87 | 28.68 | 0.82 |
| Total cost (US $)# | 11,390 | 10,689 | -700 |
| ICER (US $/QALY) | NA | Dominant |
∗Compared with the control strategy (no prevention). #All cost data were shown in the 2019 US dollar (1 US dollar = CNY ¥ 6.9).